APA (7th ed.) Citation

Usmani, S. Z., Zhang, Q., Stratton, K., Qu, P., Yaccoby, S., Hansen, E., . . . Barlogie, B. (2014). Phase II study of pomalidomide in high-risk relapsed and refractory multiple myeloma. Leukemia (08876924), 28(12), 2413. https://doi.org/10.1038/leu.2014.248

Chicago Style (17th ed.) Citation

Usmani, S Z., et al. "Phase II Study of Pomalidomide in High-risk Relapsed and Refractory Multiple Myeloma." Leukemia (08876924) 28, no. 12 (2014): 2413. https://doi.org/10.1038/leu.2014.248.

MLA (9th ed.) Citation

Usmani, S Z., et al. "Phase II Study of Pomalidomide in High-risk Relapsed and Refractory Multiple Myeloma." Leukemia (08876924), vol. 28, no. 12, 2014, p. 2413, https://doi.org/10.1038/leu.2014.248.